https://orcid.org/0009-0005-0384-5249
Figures
Abstract
We conducted a study in Georgia to examine behavioral insights and barriers to COVID-19 vaccine uptake among people living with HIV (PLWH). Between December 2021-July 2022, we collected quantitative data to evaluate participants’ demographics, COVID-19 knowledge, attitude, perception, and HIV stigma as potential covariates for being vaccinated against COVID-19. We conducted a multivariate analysis to define the factors independently associated with COVID-19 vaccination among PLWH. We collected qualitative data to explore individual experiences of their positive or negative choices, main barriers, HIV stigma, and preferences for receiving vaccination. Of the total 85 participants of the study, 52.9% were vaccinated; 61.2% had concerns with the disclosure of HIV status at the vaccination site. Those who believed they would have a severe form of COVID-19 were more likely to be vaccinated (OR = 23.8; 95% CI: 5.1–111.7). The association stayed significant after adjusting for sex, age, education level, living area, health care providers’ unfriendly attitudes, and their fear of disclosing HIV status at vaccination places. Based on the qualitative study, status disclosure was a significant barrier to receiving care; therefore, PLWH prefer to receive COVID-19 vaccination integrated in HIV services. Conclusions: In this study, around half of the participants were not vaccinated against COVID-19. The main reasons for not being vaccinated included stigma, misleading health beliefs, and low awareness about COVID-19. An integrated service delivery model may improve vaccination uptake among PLWH in Georgia.
Citation: Zurashvili T, Chakhaia T, King EJ, DeHovitz J, Djibuti M (2024) HIV stigma and other barriers to COVID-19 vaccine uptake among Georgian people living with HIV/AIDS: A mixed-methods study. PLOS Glob Public Health 4(3): e0003069. https://doi.org/10.1371/journal.pgph.0003069
Editor: Muhammad Sale Musa, Yobe State University Teaching Hospital, NIGERIA
Received: October 11, 2023; Accepted: March 8, 2024; Published: March 28, 2024
Copyright: © 2024 Zurashvili et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the manuscript and its Supporting Information files.
Funding: The research reported in this publication was supported by the Fogarty International Center, of National Institute of Alcohol Abuse and Alcoholism of the National Institutes of Health under Award Number D43 TW011532 to MD. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Introduction
HIV/AIDS and SARS-CoV-2 (COVID-19) are two major public health problems worldwide. Compared with the HIV-negative persons, people living with HIV(PLWH) have greater risk of contracting, developing complications, and dying from COVID-19 [1–3]. Therefore, vaccinating PLWH against COVID-19 is a priority public health measure to avoid complications from the disease and stop the spread of the virus. The existing literature suggests that COVID-19 vaccines are effective in PLWH [4, 5], although global uptake among this population has been reported to be 56.6% [6]. Substantial regional variations in COVID-19 vaccine uptake among PLWH are evident, with notably high rates observed in the European Region (90.1%) and the Region of the Americas (71.6%), while lower rates are reported in the Eastern Mediterranean Region (19.3%) and the African Region (35.5%) [6]. Studies also indicate that COVID-19 vaccine hesitancy (defined by the World Health Organization as the delay in acceptance or refusal of vaccination despite the availability of vaccination services [7]) is higher among this population and that factors influencing vaccine hesitancy are different for PLWH compared to HIV-negative individuals. Factors contributing to COVID-19 vaccine hesitancy among PLWH globally include perceived risks [8, 9], safety concerns [10–13], distrust in vaccine information sources, doubts about COVID-19 existence and low-risk perception [10, 14]. The study conducted among PLWH in Southwest Ethiopia indicated that the odds of intention to take the COVID-19 vaccine were 4.1 times higher among those participants who had good knowledge of COVID-19 practice compared with those who had poor knowledge [15]. The study conducted among PLWH in France reported association between a general vaccine refusal, fear of developing side effects and perception of already being immune with COVID-19 and COVID-19 vaccination hesitancy [13].
Vaccine acceptance in Eastern Europe faces challenges, with low proportions of vaccinated individuals and hesitancy influenced by factors such as public confidence in vaccine safety, efficacy, literacy, and trust in the government and medical system, underscoring the need for targeted public health initiatives to enhance COVID-19 vaccine uptake in the region [16]. In Eastern Europe and Central Asian (EECA) countries, where the HIV epidemic is escalating, our search revealed a notable gap in studies on COVID-19 vaccine acceptance, uptake and hesitancy among PLWH. This gap is particularly significant given the continued growth of the HIV epidemic in the region [17], making PLWH a crucial focus, especially considering the heightened risks associated with COVID-19. Against a backdrop of historical mistrust among citizens from the former Soviet Union towards healthcare, public institutions, medical personnel, and vaccination, a global survey identified some post-Soviet countries as having the highest hesitancy in Europe [18]. Recent research on the effects of exposure to Soviet communism on vaccine trust highlighted how socio-political regimes can adversely impact trust in vaccines, stemming from a lack of confidence in both government and healthcare providers [19]. The scarcity of data on vaccine uptake among PLWH in EECA, coupled with the unique historical context, underscores the importance of nuanced consideration in approaching vaccination attitudes. Importantly, the observed stance in the general population may not necessarily align with that of PLWH, highlighting the need for targeted research to inform tailored public health strategies for this high-risk population. The issue of COVID-19 vaccination among PLWH is important to explore in Georgia for several reasons. Foremost, overall COVID-19 vaccination rates remain suboptimal in the country. Georgia received the first batch of COVID-19 vaccine in March 2021. As of July 1st, 2022, 48.5% of adult population ages >18 was vaccinated with at least one dose and 44.9% was fully vaccinated in the same age group [20]. There is no data reported on COVID-19 vaccination specifically among PLWH in Georgia; however, we anticipate that this rate is lower compared to the general population given that little attention has been given to PLHW in the COVID-19 response in the country. To date, the country has not developed any specific plan or campaign for the vaccination of PLWH that would consider their health condition, including immune status and potential comorbidities. The other important factors impacting on vaccine uptake could be the lack of safety data on COVID-19 vaccines among PLWH as well as HIV-related stigma. To mitigate the negative effects of COVID-19 in PLWH and support the improvement of COVID-19 vaccination among this group, we explored individual level barriers by assessing the knowledge and attitude towards COVID-19 vaccination of PLWH, COVID-19, and HIV-related dual stigma and discrimination, including stigma in healthcare settings and factors associated with vaccine uptake. To explore behavioral insights and barriers to COVID-19 vaccination among PLWH, we used the Health Belief Model (HBM) [21], which has been widely used to look at COVID19 vaccine acceptance and uptake [22, 23]. The model suggests that an individual’s knowledge and beliefs about health problems, perceived threats, benefits, barriers, including stigma, have a significant influence on whether and why this individual will take action to prevent or control his/her health condition.
Methods
A cross-sectional, mixed-methods research study was conducted among adults living with HIV (>18 years old) in Georgia. The study was conducted throughout Georgia, covering the capital city, Tbilisi, as well as various regions, including Kakheti, Imereti, Guria, Samegrelo, and Ajara. Utilizing different online meeting options (e.g. Zoom, WhatsApp, Viber number, Skype, Cell Phone) during the data collection facilitated interviews with participants from diverse geographical locations.
Quantitative phase
Recruitment.
For the quantitative component, PLWH were recruited using a respondent-driven sampling (RDS) from the beneficiaries of a PLWH community-based organization “Real People Real Vision”. Eligibility criteria for PLWH included age 18 or older with self-reported HIV positive status.
Data collection.
Two study interviewers conducted data collection for the quantitative part of the study. Participants were offered the opportunity to take part in the interview via the different online meeting options (Zoom, WhatsApp, Viber number, Skype, Cell Phone). Once contacted via the preferred mode of communication, the study interviewer first conducted screening for eligibility using short screener questionnaire for PLWH, and after successful screening performed an interview using a structured questionnaire. To ensure effective recruitment and participation in the study, monetary incentives were provided to all participants.
Measurements.
The structured questionnaire was developed for the quantitative data collection considering the constructs of HBM with concrete questions for each component described below.
The outcome measure for this study was self-reported COVID-19 vaccination status, dichotomized with “Yes” and “No” responses.
Sociodemographic characteristics. The sociodemographic characteristics were participants age, sex, area of residence, education level and financial situation.
COVID-19 knowledge, attitude, perception. Information on respondents’ knowledge about COVID-19 was collected by asking whether COVID-19 and influenza were the same disease (respondents could respond, “Yes,” “No,” or “Don’t know.”), about transmission rout (i.e., droplets, sexual intercourse, blood borne) and existence of COVID-19 vaccines and medications (“Yes,” “No,” or “Don’t know.”). These questions had previously been used in a study on COVID-19 knowledge among Georgian population [24]. Attitude and perception questions asked about COVID-19 self-protection and avoidance ability, importance of COVID-19 vaccination, ways of improving the COVID-19 vaccination in general and among PLWH, and about motivations for getting vaccination, self-perceived probability and severity, perceptions related to coping with stress and recovering, trust in and use of information sources. These questions were adapted from WHO guidance for conducting behavioral insights studies related to COVID-19 [25].
HIV stigma. For measuring HIV stigma, we used 12-item HIV Stigma Scale [26]. Subscales included personalized stigma, disclosure concerns, concerns with public attitudes and negative self-image. Personalized stigma was assessed by positive response to the following three statements: “People I care about stopped calling after learning I have HIV”, “I have lost friends by telling them I have HIV” and “Some people avoid touching me once they know I have HIV”. Questions on HIV status discloser asked about keeping HIV status a secret, considering it risky to disclose it and being very careful who to tell their HIV status and positive responses indicating stigmatized attitude. Concerns about public attitudes included the following statements: “most people believe a person who has HIV is dirty; "people with HIV are treated like outcasts” and “most people are uncomfortable around someone with HIV”. Negative self-image due to being infected was assessed by positive response to the following three statements: “I feel guilty because I have HIV”, “people’s attitudes about HIV make me feel worse about myself” and “I feel I’m not as good a person as others because I have HIV”. All questions had “Yes”, “No”, “Don’t know” options for answers.
Statistical analysis.
OpenEpi v3.03, an open-source tool, was employed to determine the sample size for this study. With a 5% margin of error and a 95% confidence interval, and considering a population size of 9,400, as estimated by the World Health Organization for people living with HIV in Georgia in 2018, the recommended sample size was determined to be 370. This calculation assumed a 50% response distribution.
The main outcome of this study was binary variable—COVID-19 vaccination status (vaccinated/not vaccinated). First, bivariate analyses were used to compare PLWH’s different characteristics and outcomes. We used Chi-square and Fisher’s exact tests for categorical variables and t-test and Wilcoxon rank sum for continuous variables where appropriate. Second, we used simple logistic regression with a binary variable as the outcome. For multivariable analyses, we used logistic regression to evaluate binary variable—COVID-19 vaccination status among PLWH with different characteristics. To build the model, we used stepwise regression. First, we evaluated all variables for their unique contribution in the model. Second, if one did not contribute, we removed it from the model. However, we reentered it later, if this variable was able to explain a bit more significant variance in the dependent variable than it did when it first came in. Co-variates identified by a directed acyclic graph and/or co-variates with a p-value <0.05 in the bivariate analysis were included in the multivariable analysis. We report unadjusted and adjusted odd ratios (ORs) with 95% Confidence Intervals (CIs). A p-value of <0.05 was considered significant.
Qualitative phase
Recruitment.
For the qualitative part we selected respondents from the pool of quantitative participants who expressed interest during the survey to subsequently participate in an in-depth interview (IDI), considering the saturation of the data.
Data collection.
Two researchers experienced in qualitative research conducted IDIs among PLWH. A total of 20 individual IDIs were conducted between May-July 2022. PLWH participated in IDIs via different online meeting options (WhatsApp, Viber number, Skype, Cell Phone). The average duration for IDI was 1 hour. The IDIs were audio recorded with participants’ consent. The recordings were then transcribed verbatim and any potential identifying information removed from the transcripts.
Measurements.
A semi-structured questionnaire was developed for collecting data for the qualitative phase. The topics covered by the IDI guide included the participants’ individual experiences with vaccination, including probing questions about the factors that led to their positive or negative choices; main barriers, including HIV stigma and facilitators; personal attitudes toward the enhancement of the vaccination process; and preferences for the locations for receiving vaccination.
Statistical analysis.
The data was analyzed using an interpretive approach and categorized to identify key themes and patterns according to the HBM. Categories that followed the main topics of the interview guide, included perceived risks, attitudes barriers and facilitators that influence an individuals’ decision about getting COVID-19 vaccines.
Ethics approval
The institutional review board of the Georgian National Centre for Disease Control and Public Health (certificate IRB00002150) approved this study. All respondents were informed that their participation was voluntary and signed the informed consent form before completing the questionnaire or IDI.
Results
Quantitative phase
In Georgia, between December 2021—July 2022, 85 PLWH were screened for study eligibility, and all were enrolled (S1 Data). All of them completed the quantitative questionnaire. We observed a considerably low participation rates (85 enrolled vs 370 planned) in our study. This was one of the first studies among PLWH that used online interviewing, which might result in a low response rate. Another factor contributing to low participation rates could be accounted to widespread and deeply rooted stigma [27] towards HIV in Georgia, which could prevent PLWH’s participation in the study (even though PLWH community-based organization supported the recruitment). Another factor for consideration is the time frame of the study, which did not allow to further continue enrolment of study participants.
The median age of the participants was 43 years (IQR = 38–48). 50.6% (n = 43) of all participants were male, and 3.5% (n = 3) did not identify themselves as a man or woman. Thirty eight percent (n = 32) and 45.9% (n = 39) of all participants had completed general secondary and high education institutions, respectively. More than half of the participants reported living in urban areas, and only a fifth of all participants lived alone. Nearly all (n = 83) claimed that their financial condition worsened or remained the same during the past three months (Table 1).
Knowledge.
Less than a fifth of the respondents believed that influenza and COVID-19 are the same diseases, and around 15% (n = 12) of the interviewed participants could not answer the question about the transmission route for COVID-19. Moreover, 3.5% (n = 3) of the respondents did not believe in and 14.1% (n = 12) did not know about existence of COVID-19 vaccines. Finally, only a third of all participants believed that there are no antiviral medications against COVID-19; the rest of the respondents either thought anti-COVID-19 drugs exist or were unsure about this. Perceived Risk/Attitude: Half of the respondents did not agree that PLWH have more probability of getting COVID-19 compared to the general public. Moreover, almost half of all respondents perceived that they would not have severe forms of disease if infected with COVID-19. Almost half of the interviewed PLWH reported feeling fear and stress. COVID-19 made 40% (n = 34) of all respondents felt total helplessness; another third of the respondents held the belief that COVID-19 is something they were not confident to combat, as they believed that avoiding COVID-19 infection to be extremely difficult. At the same time, almost half of the respondents perceived that the COVID-19 situation was overhyped in the media. Along these same lines, the most trusted source of information about COVID-19 was reported to be a personal doctor among the PLHW who participated in our study. As for the attitude toward recommendations, most participants (80%, n = 68) considered mask use, hand washing, social distancing, and avoiding gatherings as activities that can help to prevent COVID-19. In contrast, less than half of the participants believed that vaccination is a way to protect oneself from COVID-19. However, almost 65% (n = 55) of participants noted that COVID-vaccination is also essential and safe for both the general public and specifically for PLWH. HIV Stigma: Personalized stigma was expressed by more than a quarter of the participants, with 25.9% (n = 22) stating that their close people stopped calling after learning their status, 27.1% (n = 23) lost friends and people avoid contact with them once they know about their status. Unlike personalized stigma, HIV status disclose concerns were more prevalent in our study participants: 34.1% (n = 29) trying hard to keep their status a secret, 47.1% (n = 40) considering it risky to disclosing their status and more than 70% (n = 62) being very careful who they tell their HIV status. In terms of concerns about public attitudes 44% (n = 37) of our study participants think that most people believe a person who has HIV is dirty; 56.5% (n = 48) stated that people with HIV are treated like outcasts and 74% (n = 63) indicated that most people are uncomfortable around someone with HIV. PLWH’s negative self-image due to being infected ranged from 8% (n = 7) feeling not being a good person because of HIV to 35% (n = 30) feeling worse about themselves due to people’s attitudes about HIV. Benefits and barriers: For most participants (72.9%, n = 62), the main benefit of the COVID-19 vaccination was that after vaccination, they would not have severe forms of COVID-19. As for barriers, 61.2% (n = 52) considered the risk of disclosing their HIV status to vaccine providers as the main barrier. Supposedly due to this barrier, most of the respondents (72.9%, n = 62) thought that having vaccination services at HIV service sites would help to improve the COVID-19 vaccination among PLWHIV. It is worth noting that PLWH did not consider HIV status-related health conditions as a barrier to vaccination (Table 2).
Slightly more than half (52.9%; n = 45) of all respondents were vaccinated. In the univariate analyses, being vaccinated was significantly associated with participants’ belief of the probability of developing the severe form of COVID-19 in case of getting infected and living in urban area (Table 3).
The results of the multivariate logistic regression analyses showed that, those who believed they would have a severe form of COVID-19 were more likely to be vaccinated (OR = 23.8; 95% CI: 5.1–111.7). The association stays significant and even increases after adjusting for sex, age, education level, and living area (aOR = 25.0; 95% CI: 5.0–125.0). In the third model, we included the variables about the participants’ opinions on health care providers’ friendly/non-friendly attitudes at vaccination places and fairness in disclosing HIV status during the vaccination. The statistically significant association between vaccination status and belief whether they develop severe form becomes more robust than in the unadjusted model (aOR = 25.7; 95% CI: 5.2–127.0) (Table 4).
Qualitative phase
A subsample of 20 participants completed an IDI in our study between June-July 2022. Among this sample, 12 reported having been vaccinated against COVID-19. Eleven participants were male. The age range was 32–68. The descriptive results below are presented according to the main topics of the IDI guide.
Perceived risks, beliefs and attitudes.
During the in-depth interviews, all vaccinated participants recalled the process as a positive experience with medical personnel expressing positive attitude towards them. In the majority of cases, it was their personal decision to get vaccinated. Voluntary vaccination was based on the knowledge of its benefits: “Vaccination was my personal decision. We had a vaccination training at my office, and after that I decided to definitely get vaccinated…”. Personal doctor’s advice or celebrity’s behavior was a trigger for some participants to get vaccination: “I saw some very famous people who got their shots, and I knew that everyone felt good, and I considered it necessary to get the one as well, because it would be good for my health. This helped me to make a decision about vaccination…”.
As for unvaccinated participants, similar to the results of the quantitative component of the study, they mostly talked about the uselessness of vaccine, since they could easily recover from the disease by themselves: “I have a strong immune system… I won’t get a severe form of COVID, so I can handle by myself… I don’t need vaccination…”, or already had contracted COVID-19 and considered it a mild disease with no complications: “I am not vaccinated. I had COVID, it was mild, and I recovered very easily…”. In the majority of cases, unvaccinated participants stated that nothing would change their decision regarding COVID-19 vaccination.
Barriers to COVID-19 vaccination for PLWH.
Vaccinated PLWH mostly stated that there are no barriers to COVID-19 vaccination based on their personal experience: “The process of vaccination was really good, I would improve just nothing…”. Both vaccinated and those who were not vaccinated respondents considered lack of information and awareness about COVID-19 vaccines as a significant barrier to COVID-19 vaccination: “The biggest barrier was probably lack of awareness, everyone was talking different things: the church, doctors, media, some of them recommended vaccination and some did no, it was really confusing…”. Another barrier stated by the respondents from both groups was HIV stigma: “Disclosing HIV status is also a problem of our society, as a rule PLWH hide information about it, and they should not, no one hides information about their diabetes, and this should be the case for HIV as well. But nobody is working on this issue, neither doctors, nor the media and it’s very bad…”, however those who were vaccinated either did not have problem with disclosure or just simply did not talk about their status to the medical personnel at the vaccination site. Majority of unvaccinated respondents stated that they simply did not want to be vaccinated, although in case they would decide to get a shot, status disclose would be a challenge for them: “I didn’t even think for a second that I should get vaccinated and if I would want, that factor [status disclosure] would be a barrier for me, I live in a village, and everyone knows me here. Stigma still exists here…”
Integration of services and a trustworthy person.
The majority of respondents, both vaccinated and unvaccinated, noted that integrating vaccination services in HIV treatment and care services would be convenient for PLWH: “Yes, it [integration] would be very convenient, I would feel more comfortable with my personal doctor, because I trust her…”. However, those who already got vaccination, do not consider vaccination sites outside HIV services being an issue: “I got vaccination outside HIV care and didn’t have any problem either, but I think it [integration] would be better, my doctor knows my status and I would be more confident…” While talking about most trustworthy person on getting general medical or COVID-19 and vaccination information/advice, the vast majority of participants talked only about their personal doctors/infectious disease specialist.
Discussion
The main finding of our study was the low coverage of vaccination (only slightly more than half) among PLWH. Our finding is slightly lower than a global COVID-19 vaccine uptake among PLWH of 56.6%, but at the same time notably lower than the rate of 90.1% for the European Region as reported by Sulaiman et al. [6]. When considering the broader context, our findings also underscore a significant gap compared to the global vaccine uptake among the general population, which stands at a higher rate of 70.6% [28]. Results from our research highlight three main reasons for PLWH not being vaccinated: misleading health beliefs, low awareness about COVID-19, and stigma.
Most participants believed they have a low probability of developing severe disease after being infected with COVID-19. At the same time, for these respondents, the main benefit of the COVID-19 vaccination was that after vaccination, they would not have severe forms of COVID-19. These contradictory beliefs might cause reluctance regarding the necessity of getting COVID-19 vaccination. Unadjusted and adjusted statistically significant associations between being vaccinated and participants’ opinion of the probability of developing severe COVID-19 in case of getting infected proved the above statement. In-depth interviews, during which unvaccinated respondents mostly talked about the uselessness of COVID-19 vaccines since they could quickly recover from the mild disease with no complications, also confirmed these findings. A systematic review and meta-analysis conducted by Sulaiman et al. reported association of perceived high susceptibility to SARS-CoV-2 infection and a strong belief in the vaccine’s effectiveness and utility with higher COVID-19 vaccine acceptance and uptake among PLWH [6]. HBM constructs, such as perceived severity of COVID-19 infection and perceived benefits of a COVID-19 vaccine have also been linked to vaccination acceptability among general population [29, 30]. The results highlight the interconnected role of risk perception and perceived vaccine benefits in influencing vaccination behavior.
Stigma was another main reason for vaccine non-uptake among PLWH. According to our quantitative analyses, the risk of disclosing their HIV status to vaccine providers is the main barrier for HIV-positive respondents. This finding is in line with our qualitative findings. During the IDIs, respondents noted that PLWH prefer not to disclose information about their HIV status. Supposedly due to this barrier, most PLWH expressed that having vaccination services at HIV service sites would be convenient for getting a vaccination. The study conducted among Chinese PLWH also revealed apprehensions regarding the disclosure of HIV status in the context of COVID-19 vaccination [8]. The low vaccine uptake among marginalized populations, including PLWH in India, has been attributed to factors such as HIV-related stigma, fear of disclosing HIV status, and a scarcity of communication materials tailored for these groups, exacerbating the challenge of combating COVID-19 in these vulnerable communities [31].
Finally, our study’s quantitative and qualitative data showed that PLWH lack knowledge regarding COVID-19. These findings are in line with the study conducted among PLWH in Southwest Ethiopia, which revealed the importance of knowledge in acceptance of COVID-19 vaccination [15]. During the in-depth interviews, unvaccinated respondents named misinformation and lack of trusted sources as significant barriers. Their main concern was that various sources, such as media, health institutions, churches, etc., spread different recommendations regarding the COVID-19 vaccination. The findings from a study conducted in in British Columbia, Canada is also illustrative of inconsistency between the strong recommendations for COVID-19 vaccination for PLWH and existing intentions [32]. Qualitative and quantitative analyses showed that personal doctors are the most trusted source of information for PLWH. Therefore, medical doctors working with HIV-positive people should conduct more COVID-19-related education activities among their patients. The findings from a study among PLWH at a primary care clinic in an urban area of New York City highlight the significance of physicians’ active engagement in individualized education with PLWH leading to an increased vaccine acceptance [33]. HCWs should mainly focus on COVID-19 and HIV dual stigma-related issues and misleading beliefs about developing severe disease among PLWH. A systematic approach to the education sessions would help to increase knowledge and raise awareness about COVID-19 among PLWH.
This study had several limitations. First, the quantitative part was a cross-sectional study, so no causality could be established. The sampling method used (non-probability) for this study makes it difficult to infer the results to the entire PLWH population in Georgia. In our study, the vaccination status was self-reported, however it has been shown that in large observational studies where medical records are not available, self-reported dates and product details for COVID-19 vaccination can be a good substitute [34].
Conclusion
This study was the first in the ECCA region to explore the factors associated with COVID-19 vaccine uptake specifically among PLWH. According to our findings, around half of the PLWH were not vaccinated against COVID-19. We identified that the main reasons for not being vaccinated among PLWH were (1) stigma, (2) misleading health beliefs and (3) low awareness about COVID-19.
COVID-19 awareness raising campaigns and educational sessions should be continually conducted among PLWH. Medical doctors and mainly, HIV service providers as the most trusted source of information for PLWH, should work closely with their patients to support the improvement of COVID-19 vaccination among PLWH in Georgia.
Supporting information
S1 Data. Study dataset.
This dataset comprises anonymized records of participants involved in the study in the format of Excel spreadsheet. It includes information on demographics, COVID-19 vaccination status, knowledge, attitudes, and perceptions related to COVID-19, as well as barriers and facilitators to COVID-19 vaccination. The dataset encompasses data on HIV and HIV and COVID dual stigma among participants.
https://doi.org/10.1371/journal.pgph.0003069.s001
(XLSX)
Acknowledgments
The authors thank local PLWH community-based organization “Real People Real Vision” for assistance in the field work and recruitment of participants for this study.
References
- 1. Bertagnolio S, Thwin SS, Silva R, Nagarajan S, Jassat W, Fowler R, et al. Clinical features of, and risk factors for, severe or fatal COVID-19 among people living with HIV admitted to hospital: analysis of data from the WHO Global Clinical Platform of COVID-19. Lancet HIV. 2022;9(7):e486–e95. pmid:35561704
- 2. Mellor MM, Bast AC, Jones NR, Roberts NW, Ordonez-Mena JM, Reith AJM, et al. Risk of adverse coronavirus disease 2019 outcomes for people living with HIV. AIDS. 2021;35(4):F1–F10. pmid:33587448
- 3. Ssentongo P, Heilbrunn ES, Ssentongo AE, Advani S, Chinchilli VM, Nunez JJ, et al. Epidemiology and outcomes of COVID-19 in HIV-infected individuals: a systematic review and meta-analysis. Sci Rep. 2021;11(1):6283. pmid:33737527
- 4. Bekker LG, Garrett N, Goga A, Fairall L, Reddy T, Yende-Zuma N, et al. Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study. Lancet. 2022;399(10330):1141–53. pmid:35305740
- 5. Levy I, Wieder-Finesod A, Litchevsky V, Biber A, Indenbaum V, Olmer L, et al. Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1. Clin Microbiol Infect. 2021;27(12):1851–5. pmid:34438069
- 6. Sulaiman SK, Musa MS, Tsiga-Ahmed FI, Sulaiman AK, Bako AT. A systematic review and meta-analysis of the global prevalence and determinants of COVID-19 vaccine acceptance and uptake in people living with HIV. Nature Human Behaviour [Internet]. 2024 Jan 1 [cited 2024 Feb 2];8(1):100–14. Available from: https://www.nature.com/articles/s41562-023-01733-3 pmid:37904021
- 7. WHO. Report of the SAGE Working Group on vaccine hesitancy. 2014.
- 8. Yao Y, Chai R, Yang J, Zhang X, Huang X, Yu M, et al. Reasons for COVID-19 Vaccine Hesitancy Among Chinese People Living With HIV/AIDS: Structural Equation Modeling Analysis. JMIR Public Health Surveill. 2022;8(6):e33995. pmid:35486810
- 9. Kabir Sulaiman S, Sale Musa M, Isma’il Tsiga-Ahmed F, Muhammad Dayyab F, Kabir Sulaiman A, Dabo B, et al. COVID-19 vaccine hesitancy among people living with HIV (PLHIV) in a low-resource setting: a multi-center study of prevalence, correlates and reasons. Vaccine. 2023 Feb;
- 10. Ekstrand ML, Heylen E, Gandhi M, Steward WT, Pereira M, Srinivasan K. COVID-19 Vaccine Hesitancy Among PLWH in South India: Implications for Vaccination Campaigns. J Acquir Immune Defic Syndr. 2021;88(5):421–5. pmid:34757971
- 11. Shrestha R, Meyer JP, Shenoi S, Khati A, Altice FL, Mistler C, et al. COVID-19 Vaccine Hesitancy and Associated Factors among People with HIV in the United States: Findings from a National Survey. Vaccines. 2022 Mar 10;10(3):424. pmid:35335054
- 12. Liu Y, Han J, Li X, Chen D, Zhao X, Qiu Y, et al. COVID-19 Vaccination in People Living with HIV (PLWH) in China: A Cross Sectional Study of Vaccine Hesitancy, Safety, and Immunogenicity. Vaccines. 2021 Dec 9;9(12):1458. pmid:34960204
- 13. Vallée A, Fourn E, Majerholc C, Touche P, Zucman D. COVID-19 Vaccine Hesitancy among French People Living with HIV. Vaccines. 2021 Mar 24;9(4):302. pmid:33804808
- 14. Bogart LM, Ojikutu BO, Tyagi K, Klein DJ, 1Mutchler MG, Dong L, et al. COVID-19 related medical mistrust, health impacts, and potential vaccine hesitancy among black Americans living with HIV. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2020 Nov 9;86(2).
- 15. Mesfin Y, Argaw M, Geze S, Zewdu BT. Factors Associated with Intention to Receive COVID-19 Vaccine Among HIV Positive Patients Attending ART Clinic in Southwest Ethiopia. Patient Prefer Adherence. 2021;15:2731–8. pmid:34916783
- 16. Popa AD, Enache AI, Popa IV, Antoniu SA, Dragomir RA, Burlacu A. Determinants of the Hesitancy toward COVID-19 Vaccination in Eastern European Countries and the Relationship with Health and Vaccine Literacy: A Literature Review. Vaccines. 2022 Apr 23;10(5):672. pmid:35632428
- 17. The path that ends AIDS: UNAIDS Global AIDS Update 2023. 2023.
- 18. Lazarus JV, Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K, et al. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021;27(2):225–8. pmid:33082575
- 19. Costa-Font J, Garcia-Hombrados J, Nicinska A. The institutional origins of vaccines distrust: Evidence from former-Soviet countries. PLoS One. 2023;18(3):e0282420. pmid:36857365
- 20. NCDC. National Center for Disease Control and Public Health report on COVID-19 in Georgia. 2020–2022.
- 21. Karen Glanz BV K. Health behavior: theory, research, and practice. Fifth edition 2015.
- 22. Limbu YB, Gautam RK, Pham L. The Health Belief Model Applied to COVID-19 Vaccine Hesitancy: A Systematic Review. Vaccines (Basel). 2022;10(6). pmid:35746581
- 23. Zampetakis LA, Melas C. The health belief model predicts vaccination intentions against COVID-19: A survey experiment approach. Appl Psychol Health Well Being. 2021;13(2):469–84. pmid:33634930
- 24. Butsashvili M, Gulbiani L, Kanchelashvili G, Kochlamazashvili M, Nioradze G, Kamkamidze T, et al. Knowledge Related to the Novel Coronavirus (Sars-Cov-2) among Georgian Population. Georgian Med News. 2022(322):66–75. pmid:35134763
- 25. SURVEY TOOL AND GUIDANCE Rapid, simple, flexible behavioural insights on COVID-19 [Internet]. 2020 [cited 2023 Oct 1]. Available from: https://studiocovidoms.it/wp-content/uploads/2020/12/Protocollo-studio-Europeo.pdf
- 26. Reinius M, Wettergren L, Wiklander M, Svedhem V, Ekstrom AM, Eriksson LE. Development of a 12-item short version of the HIV stigma scale. Health Qual Life Outcomes. 2017;15(1):115. pmid:28558805
- 27. Magnani R, Sabin K, Saidel T, Heckathorn D. Review of sampling hard-to-reach and hidden populations for HIV surveillance. AIDS. 2005 May;19(Supplement 2):S67–72. pmid:15930843
- 28. Our World in Data. Coronavirus (COVID-19) Vaccinations—Statistics and Research [Internet]. Our World in Data. 2023. Available from: https://ourworldindata.org/covid-vaccinations
- 29. Reiter PL, Pennell ML, Katz ML. Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated? Vaccine. 2020;38(42):6500–7. pmid:32863069
- 30. Shmueli L. Predicting intention to receive COVID-19 vaccine among the general population using the health belief model and the theory of planned behavior model. BMC Public Health. 2021;21(1):804. pmid:33902501
- 31.
COVID-19 vaccination among key populations and people living with HIV [Internet]. Available from: https://www.fhi360.org/sites/default/files/media/documents/resource-epic-increasing-vaccination-india-success-story.pdf
- 32. Kaida A, Brotto LA, Murray MCM, Cote HCF, Albert AY, Nicholson V, et al. Intention to Receive a COVID-19 Vaccine by HIV Status Among a Population-Based Sample of Women and Gender Diverse Individuals in British Columbia, Canada. AIDS Behav. 2022;26(7):2242–55. pmid:35020094
- 33.
Buckley MaS, Kevinand Spier, Daniel and Stefanov, Dimitre and Ahmadi, Ladan. Attitudes Towards COVID-19 Vaccination in People Living with HIV (PLWHIV) at an Urban Primary Care Clinic.
- 34. Tjaden AH, Fette LM, Edelstein SL, Gibbs M, Hinkelman AN, Runyon M, et al. Self-Reported SARS-CoV-2 Vaccination Is Consistent with Electronic Health Record Data among the COVID-19 Community Research Partnership. Vaccines (Basel). 2022;10(7). pmid:35891180